ADIPOQ and diabetes mellitus: Administration of recombinant adiponectin or genetic overexpression of adiponectin in rodent models has therapeutic effects in diabetes, ischemic cardiac injury and in colon cancer [10], [11], [12], [13], [14], [15], [16].